[go: up one dir, main page]

WO1997039722A3 - Procede pour isoler les regulateurs de l'activation des lymphocytes t - Google Patents

Procede pour isoler les regulateurs de l'activation des lymphocytes t Download PDF

Info

Publication number
WO1997039722A3
WO1997039722A3 PCT/US1997/007052 US9707052W WO9739722A3 WO 1997039722 A3 WO1997039722 A3 WO 1997039722A3 US 9707052 W US9707052 W US 9707052W WO 9739722 A3 WO9739722 A3 WO 9739722A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell activation
regulators
isolating
composition
primary screen
Prior art date
Application number
PCT/US1997/007052
Other languages
English (en)
Other versions
WO1997039722A2 (fr
Inventor
Augustine Y Lin
Scott W Umlauf
Andreas G Batzer
Original Assignee
T Cell Sciences Inc
Augustine Y Lin
Scott W Umlauf
Andreas G Batzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc, Augustine Y Lin, Scott W Umlauf, Andreas G Batzer filed Critical T Cell Sciences Inc
Priority to AU28148/97A priority Critical patent/AU2814897A/en
Publication of WO1997039722A2 publication Critical patent/WO1997039722A2/fr
Publication of WO1997039722A3 publication Critical patent/WO1997039722A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Criblage préliminaire de haute capacité à étapes multiples pour identifier les régulateurs immunitaires de l'activation des lymphocytes T, à utiliser en tant qu'agents thérapeutiques. Des compositions ou des composés sont criblés. On analyse les capacités de compositions ou de composés de stimuler ou d'inhiber l'expression d'un gène reporter lié de manière fonctionnelle à des séquences spécifiques de régulation transcriptionnelle dans les lymphocytes T. On peut caractériser de manière plus aprofondie une composition ou un composé identifié comme un stimulant ou un inhibiteur immunitaire au moyen de criblage selon l'invention, afin de déterminer la molécule cible sur laquelle la composition ou le composé agir pour régler l'activation des lymphocytes T et les processus dépendant de cette activation, comme l'apoptose.
PCT/US1997/007052 1996-04-25 1997-04-25 Procede pour isoler les regulateurs de l'activation des lymphocytes t WO1997039722A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU28148/97A AU2814897A (en) 1996-04-25 1997-04-25 Method of isolating regulators of t cell activation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63928696A 1996-04-25 1996-04-25
US08/639,286 1996-04-25

Publications (2)

Publication Number Publication Date
WO1997039722A2 WO1997039722A2 (fr) 1997-10-30
WO1997039722A3 true WO1997039722A3 (fr) 1998-07-16

Family

ID=24563494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/007052 WO1997039722A2 (fr) 1996-04-25 1997-04-25 Procede pour isoler les regulateurs de l'activation des lymphocytes t

Country Status (2)

Country Link
AU (1) AU2814897A (fr)
WO (1) WO1997039722A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US9528088B2 (en) 2002-06-28 2016-12-27 Life Technologies Corporation Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650714A1 (de) * 1996-12-06 1998-06-10 Melchner Harald Von Prof Dr Genfallen-Konstrukt zur Identifizierung und Isolierung von Genen
US5994507A (en) * 1997-12-31 1999-11-30 Amersham Pharmacia Biotech Ab Method for binding albumin and means to be used in the method
EP1041144B1 (fr) * 1999-03-29 2004-06-23 Michael Blind Procédé pour l'identification et la validation des cibles au moyen des intramers ou de la selection in vivo
WO2001079555A2 (fr) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles des membres de la famille jak/stat dans l'induction de la tolerance
US20060040249A1 (en) * 2002-09-26 2006-02-23 Manfred Auer Screening method involving transfected primary cells
AU2003304486A1 (en) * 2003-09-26 2005-04-14 Department Of Biogenic Amines, Polish Academy Of Sciences Cells and methods useful in characterising the immunotoxic activity of xenobiotic substances
CN109073635A (zh) * 2016-01-25 2018-12-21 豪夫迈·罗氏有限公司 用于测定t细胞依赖性双特异性抗体的方法

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007487A1 (fr) * 1989-11-16 1991-05-30 Duke University Transformation de cellules tissulaires animales a l'aide de particules
EP0519336A2 (fr) * 1991-06-18 1992-12-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Géne chimérique comprenant un promoteur-régulateur et un gène codant pour une protéine indicatrice
WO1993004203A1 (fr) * 1991-08-22 1993-03-04 The Board Of Trustees Of The Leland Stanford Jr. University Procedes de depistage d'agents immunosuppressifs
WO1995008554A1 (fr) * 1993-09-20 1995-03-30 The Board Of Trustees Of The Leland Stanford Junior University Polypeptides et polynucleotides nf-at
WO1995015173A1 (fr) * 1993-11-30 1995-06-08 Lxr Biotechnology Inc. Compositions inhibant l'apoptose, leurs procedes de purification et leurs utilisations
WO1995018972A1 (fr) * 1994-01-05 1995-07-13 Arqule, Inc. Production modulaire systematique de molecules a base d'aminimide et d'oxazolone ayant des proprietes choisies
WO1995027735A1 (fr) * 1994-04-08 1995-10-19 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibiteur d'apoptose
WO1996035953A1 (fr) * 1995-05-11 1996-11-14 Arqule, Inc. Synthese combinatoire et detection a rendement eleve d'un reseau a base d'arylidenediamide inhibant la fixation de la proteine rev
EP0763597A2 (fr) * 1995-09-14 1997-03-19 Hoechst Aktiengesellschaft Utilisation de peptides cytohésine-PH pour influencer la capacité d'adhésion des integrines
WO1997040022A1 (fr) * 1996-04-25 1997-10-30 T Cell Sciences, Inc. Composes immunosuppresseurs selectionnes dans une serie de diamides d'arylidene

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007487A1 (fr) * 1989-11-16 1991-05-30 Duke University Transformation de cellules tissulaires animales a l'aide de particules
EP0519336A2 (fr) * 1991-06-18 1992-12-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Géne chimérique comprenant un promoteur-régulateur et un gène codant pour une protéine indicatrice
WO1993004203A1 (fr) * 1991-08-22 1993-03-04 The Board Of Trustees Of The Leland Stanford Jr. University Procedes de depistage d'agents immunosuppressifs
WO1995008554A1 (fr) * 1993-09-20 1995-03-30 The Board Of Trustees Of The Leland Stanford Junior University Polypeptides et polynucleotides nf-at
WO1995015173A1 (fr) * 1993-11-30 1995-06-08 Lxr Biotechnology Inc. Compositions inhibant l'apoptose, leurs procedes de purification et leurs utilisations
WO1995018972A1 (fr) * 1994-01-05 1995-07-13 Arqule, Inc. Production modulaire systematique de molecules a base d'aminimide et d'oxazolone ayant des proprietes choisies
WO1995027735A1 (fr) * 1994-04-08 1995-10-19 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibiteur d'apoptose
WO1996035953A1 (fr) * 1995-05-11 1996-11-14 Arqule, Inc. Synthese combinatoire et detection a rendement eleve d'un reseau a base d'arylidenediamide inhibant la fixation de la proteine rev
EP0763597A2 (fr) * 1995-09-14 1997-03-19 Hoechst Aktiengesellschaft Utilisation de peptides cytohésine-PH pour influencer la capacité d'adhésion des integrines
WO1997040022A1 (fr) * 1996-04-25 1997-10-30 T Cell Sciences, Inc. Composes immunosuppresseurs selectionnes dans une serie de diamides d'arylidene

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DHEIN J ET AL: "AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95)", NATURE, vol. 373, 2 February 1995 (1995-02-02), pages 438 - 441, XP002035056 *
JEITNER T M ET AL.: "Thiol-bearing compounds selectively inhibit protein kinase C-dependent events and proliferation in human T cells", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1223, no. 1, 1994, pages 15 - 22, XP002063832 *
NORTHROP J P ET AL: "CHARACTERIZATION OF THE NUCLEAR AND CYTOPLASMIC COMPONENTS OF THE LYMPHOID-SPECIFIC NUCLEAR FACTOR OF ACTIVATED T CELLS (NF-AT) COMPLEX", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 4, 5 February 1993 (1993-02-05), pages 2917 - 2923, XP002053814 *
SU B ET AL: "JNK IS INVOLVED IN SIGNAL INTEGRATION DURING COSTIMULATION OF T-LYMHOCYTES", CELL, vol. 77, 3 June 1994 (1994-06-03), pages 727 - 736, XP002053843 *
UMLAUF S A ET AL: "DISCOVERY OF NOVEL IMMUNOMODULATORY COMPOUNDS BY FUNCTIONAL SCREENING OF A SYNTHETIC ARRAY LIBRARY", FASEB JOURNAL, vol. 10, no. 6, 30 April 1996 (1996-04-30), pages A1453, XP002053816 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US9528088B2 (en) 2002-06-28 2016-12-27 Life Technologies Corporation Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation

Also Published As

Publication number Publication date
AU2814897A (en) 1997-11-12
WO1997039722A2 (fr) 1997-10-30

Similar Documents

Publication Publication Date Title
Lechat et al. PrCYP707A1, an ABA catabolic gene, is a key component of Phelipanche ramosa seed germination in response to the strigolactone analogue GR24
WO1997039722A3 (fr) Procede pour isoler les regulateurs de l'activation des lymphocytes t
Li et al. Comparative proteome analyses of phosphorus responses in maize (Zea mays L.) roots of wild‐type and a low‐P‐tolerant mutant reveal root characteristics associated with phosphorus efficiency
AU7926098A (en) Methods and means for control of flowering in plants
CA2094144A1 (fr) Methodes relatives a des elements genetiques suppresseurs efficaces et leurs applications
WO2003064615A3 (fr) Reduction d'amplifications dependantes d'acides nucleiques non vises: amplification de sequences d'acide nucleique repetitif
ATE456372T1 (de) Haftklebende n,o-carboxy methylchitosan beschichtungen, die die befestigung von zellen und proteinen mit den sustraten hemmen.
CA2515338A1 (fr) Inhibiteurs de l'histone deacetylase
MX9708663A (es) Inhibidor de actividad il-6.
AU2001248701A1 (en) Inhibitors of histone deacetylase
MXPA04002397A (es) Inhibidores de histona deacetilasa.
WO2001016114A3 (fr) Composes et techniques permettant de moduler la fonction du recepteur cxcr3
MX9705039A (es) Genes y proteinas de muerte celular programada.
WO2003088917A3 (fr) Regulation du tnf alpha
CA2259123A1 (fr) Oligonucleotides provenant des regions non traduites de genes constitutifs, et procede d'utilisation de ces oligonucleotides afin de moduler la croissance cellulaire
WO1995001439A3 (fr) Vegetaux presentant une reponse modifiee a l'ethylene
AU3993097A (en) Delta 16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors
AU7548500A (en) Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
WO2005065339A3 (fr) Genes de cycles cellulaires et leurs procedes d'utilisation associes
NO20010956D0 (no) Modulering av hukommelseseffektor T-celler samt midler for dette
WO2020068304A3 (fr) Inhibiteurs de liaison de cible de nucléase guidée par arn et leurs utilisations
DE60332600D1 (de) Selektive elution von immobilisierten multiplexierten primerverlängerungsprodukten
AU3770897A (en) Process for the production of grain oriented silicon steel sheet
NO943765L (no) Aryloksybenzen-herbicidmidler
WO2004060878A3 (fr) Inhibiteurs de phosphatases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97537505

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase